Based on the data presented, we proposed a vital role and potential regulatory mechanism of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3, also called IMP3) in gliomas. This evidence concerns the gene IGF2BP3 and central nervous system cancer.